Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Efgartigimod for Sjogren's Syndrome
Recruiting1 awardPhase 3
Clearwater, Florida
This trial aims to test if efgartigimod PH20 SC is effective in treating patients with moderate-to-severe Primary Sjögren's Disease. The study will have two parts:
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.